Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Cash & Equivalents (2016 - 2025)

Immuron has reported Cash & Equivalents over the past 10 years, most recently at $1.8 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 76.4% year-over-year to $1.8 million; the TTM value through Jun 2025 reached $1.8 million, down 76.4%, while the annual FY2025 figure was $1.8 million, 76.0% down from the prior year.
  • Cash & Equivalents for Q2 2025 was $1.8 million at Immuron, down from $7.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $17.4 million in Q3 2022 and troughed at $171597.6 in Q3 2023.
  • A 5-year average of $7.7 million and a median of $7.7 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 99.01% in 2023 and later surged 6693.4% in 2024.
  • Year by year, Cash & Equivalents stood at $2.4 million in 2021, then skyrocketed by 594.97% to $16.5 million in 2022, then tumbled by 32.12% to $11.2 million in 2023, then plummeted by 31.76% to $7.6 million in 2024, then plummeted by 76.22% to $1.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for IMRN at $1.8 million in Q2 2025, $7.6 million in Q4 2024, and $11.7 million in Q3 2024.